» Articles » PMID: 33233367

Human Fungal Infections in Kuwait-Burden and Diagnostic Gaps

Overview
Journal J Fungi (Basel)
Date 2020 Nov 25
PMID 33233367
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Fungal infections are an increasingly important public health issue, yet accurate statistics on fungal burden worldwide and in Kuwait are scarce. Here we estimate the incidence and prevalence of fungal infections in Kuwait. Population statistics from 2018 collected by the Public Authority for Civil Information were used, as well as data from the Ministry of Health. A literature search for Kuwait data on mycotic diseases and population at risk (chronic obstructive pulmonary disease, HIV infection/AIDS, cancer, and transplant patients) was conducted. The population in 2018 was estimated at 4,226,920 million people: 1,303,246 million Kuwaitis and 2,923,674 million expatriates. We determined the annual burden of serious fungal infections number (per 100,000) from high to low based on earlier reported fungal rates for populations at risk: recurrent vaginitis 54,842 (2595); severe asthma with fungal sensitisation 10,411 (246); allergic bronchopulmonary aspergillosis, 7887 (187); chronic pulmonary aspergillosis 995 (21.3); invasive aspergillosis 704 (16.7); fungal keratitis 654 (15.5); candidaemia 288 (6.8); peritonitis 63 (3.5) and oesophageal candidiasis in HIV 33 (0.8). Besides identifying rising new risk groups and expanding reports on antifungal resistance, surveillance programs and further epidemiological studies are needed to achieve more precise assessments of fungal disease epidemiology and correlated morbidity and mortality.

Citing Articles

Non-Candida mycosis in Gulf Cooperation Council (GCC) countries: perspective of a low-incidence region.

Alsaleh A, Shahid M BMC Infect Dis. 2025; 25(1):253.

PMID: 39988654 PMC: 11849344. DOI: 10.1186/s12879-025-10680-5.


First Reported Case of Breast Sporotrichosis in Bahrain.

Al Saad S, Al Shenawi H, Tyminski H, Chandran N, Farid E, Al Shenawi N Cureus. 2024; 16(11):e74128.

PMID: 39712691 PMC: 11662196. DOI: 10.7759/cureus.74128.


The Rising Threat of Mucormycosis: Oman's Experience Before and During the COVID-19 Pandemic.

Al-Jardani A, Al-Wahaibi A, Al Rashdi A, Spruijtenburg B, AlBulushi N, Rani R J Fungi (Basel). 2024; 10(11).

PMID: 39590715 PMC: 11595873. DOI: 10.3390/jof10110796.


A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole.

Thompson 3rd G, Chen S, Alfouzan W, Izumikawa K, Colombo A, Maertens J Med Mycol. 2024; 62(9).

PMID: 39138063 PMC: 11382804. DOI: 10.1093/mmy/myae083.


Mapping the Burden of Fungal Diseases in the United Arab Emirates.

Dhaheri F, Thomsen J, Everett D, Denning D J Fungi (Basel). 2024; 10(5).

PMID: 38786708 PMC: 11121979. DOI: 10.3390/jof10050353.


References
1.
Leonardelli F, Macedo D, Dudiuk C, Cabeza M, Gamarra S, Garcia-Effron G . Aspergillus fumigatus Intrinsic Fluconazole Resistance Is Due to the Naturally Occurring T301I Substitution in Cyp51Ap. Antimicrob Agents Chemother. 2016; 60(9):5420-6. PMC: 4997867. DOI: 10.1128/AAC.00905-16. View

2.
Al-Jasser A, Elkhizzi N . Distribution of Candida species among bloodstream isolates. Saudi Med J. 2004; 25(5):566-9. View

3.
Zaki S, Denning D . Serious fungal infections in Egypt. Eur J Clin Microbiol Infect Dis. 2017; 36(6):971-974. DOI: 10.1007/s10096-017-2929-4. View

4.
Hammond E, McDonald C, Vestbo J, Denning D . The global impact of Aspergillus infection on COPD. BMC Pulm Med. 2020; 20(1):241. PMC: 7488557. DOI: 10.1186/s12890-020-01259-8. View

5.
Denning D, Kneale M, Sobel J, Rautemaa-Richardson R . Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018; 18(11):e339-e347. DOI: 10.1016/S1473-3099(18)30103-8. View